Chronic GVHD therapies offer hope for treating refractory diseaseFebruary 17, 2021TransplantMyelodysplastic SyndromeMultiple MyelomaALLAMLDLBCLB Cell Lymphoma
COVID-19 vaccination in cancer patients: NCCN outlines prioritiesFebruary 1, 2021COVID-19 UpdatesTransplantPatient & Survivor Care
Caregiver burden of outpatient ASCT for multiple myeloma comparable with inpatient transplantDecember 18, 2020Multiple MyelomaTransplant
Extended virus shedding after COVID-19 in some patients with cancerDecember 10, 2020Patient & Survivor CareCOVID-19 UpdatesTransplantMultiple MyelomaMyelodysplastic Syndrome
‘Practice changing’: Ruxolitinib as second-line in chronic GVHDDecember 8, 2020TransplantPatient & Survivor Care
Allogeneic transplant leads to durable remissions in T-cell lymphomasDecember 6, 2020T Cell LymphomasTransplant
Prevention of HMA failure a goal for high-risk MDS posttransplantNovember 13, 2020TransplantAMLMyelodysplastic Syndrome
Are HMAS appropriate for posttransplant maintenance in acute leukemias?November 5, 2020ALLTransplantAMLMyelodysplastic Syndrome
Novel treatments under study for chronic graft-versus-host disease in allo-HCTOctober 27, 2020Transplant
Tandem transplantation, long-term maintenance may extend MM remissionJune 11, 2020Multiple MyelomaTransplantMixed Topics
